Pregnancy in women with solid-organ transplants: A review

Obstetrical and Gynecological Survey

Volumn 70, Issue 6, 2015, Pages 408-418

  Durst, Jennifer K ^a   Rampersad, Roxane M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BELATACEPT; CONTRACEPTIVE AGENT; CORTICOSTEROID; CYCLOSPORIN; EVEROLIMUS; MERCAPTOPURINE; MYCOPHENOLATE MOFETIL; PREDNISONE; RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

CESAREAN SECTION; CONTRACEPTION; CYSTIC FIBROSIS; DRUG SAFETY; ECHOCARDIOGRAPHY; FETUS OUTCOME; FETUS RISK; FULMINANT HEPATIC FAILURE; GESTATIONAL AGE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIGH RISK POPULATION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LACTATION; LEUKOCYTE COUNT; LIFE EXPECTANCY; LIMB REDUCTION DEFECT; LIVER TRANSPLANTATION; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MEDICINE; MULTIPLE PREGNANCY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PERINATAL CARE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURE LABOR; PREMATURITY; PUBLIC HEALTH SERVICE; REVIEW; SPONTANEOUS ABORTION; STILLBIRTH; ADULT; ADVERSE EFFECTS; ALLOGRAFT; DRUG EFFECTS; FEMALE; HIGH RISK PREGNANCY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATIONS; PROCEDURES;

ADULT; ALLOGRAFTS; CONTRACEPTION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LACTATION; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH;

EID: 84931070573     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0000000000000194     Document Type: Review

References (60)

1. Murray JE, Reid DE, Harrison JH, et al. Successful pregnancies after human renal transplantation. N Engl J Med. 1963;269:341-343.
2. National Transplantation Pregnancy Registry (NTPR). 2013 Annual Report. Philadelphia, PA: Gift of Life Institute; 2014.
3. McKay DB, Josephson MA. Reproduction and Transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant. 2005;5:1592-1599.
4. Cardonick E, Mortiz M, Armenti V. Pregnancy in patients with organ transplantation: a review. Obstet Gynecol Surv. 2004;59:214-222.
5. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:1-40.
6. Mastrobattista JM, Gomez-Lopez V. Pregnancy after solid organ transplantation. Obstet Gynecol. 2008;112:919-932.
7. Ross LF. Ethical considerations related to pregnancy in transplant recipients. N Engl J Med. 2006;354:1313-1316.
8. Kim HW, Seok HJ, Kim TH, et al. The experience ofpregnancy after renal transplantation: pregnancies even within postoperative 1 year may be tolerable. Transplantation. 2008;85:1412-1419.
9. Bonanno C, Dove L. Pregnancy after liver transplantation. Semin Perinatol. 2007;31:348-353.
10. Costanzo MR, Dipchang A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Tranplant. 2010;29:914-956.
11. Deshpande NA, James NT, Kucirka LM, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11:2388-2404.
12. Richman K, Gohh R. Pregnancy after renal transplantation: a review of registry and single-center practices and outcomes. Nephrol Dial Transplant. 2012;27:3428-3434.
13. Deshpande NA, James NT, Kucirka LM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl. 2012;18:621-629.
14. Jabiry-Zieniewicz Z, Dabrowski FA, Pietrzak B, et al. Pregnancy complications after liver transplantation. Int J Gynecol Obstet. 2015;128:27-29.
15. Mohamed-Ahmed O, Nelson-Piercy C, Bramham K, et al. Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK National Cohort Study. PLoS One. 2014;9:e89151.
16. Ramirez CB, Doria C. Pregnancy after liver transplantation. Best Pract Res Clin Obstet Gynaecol. 2014;28:1137-1145.
17. Maddukuri VC, Stephenson CD, Eskind L, et al. Liver transplantation for acute liver failure at 11-week gestation with successful maternal and fetal outcome. Case Rep Transplant. 2012 484080. doi:10.1155/2012/484080.
18. Brosens I, Pijnenborg R, Benagiano G. Risk of Obstetrical Complications in Organ Transplant Recipient Pregnancies. Transplantation. 2013;96:227-233.
19. OPTN/SRTR 2012 Annual Data Report: Lung. Scientific Registry of Transplant Recipients. Available at: Srtr.transplant.hrsa.gov/annual-reports/2012/pdf/06-lung-13.pdf. Accessed November 17, 2014.
20. Nguyen ML, Flowers L. Cervical cancer screening in immunocom-promised women. Obstet Gynecol Clin North Am. 2013;40:339-357.
21. Vos R, Ruttens D, Verleden SE, et al. Pregnancy after heart and lung transplantation. Best Pract Res Clin Obstet Gynaecol. 2014;28:1146-1162.
22. Cowan SW, Davison JM, Doria C, et al. Pregnancy after cardiac transplantation. Cardiol Clin. 2012;30:441-452.
23. Abdalla M, Mancini DM. Management of pregnancy in the post-cardiac transplant patient. Semin Perinatol. 2014;38:318-325.
24. Food and Drug Administration. DepartmentofHealth and Human Services. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Available at: http://www.regulations.gov/contentStreamer?objectId=09000064806051dd&disposition= attachment&contentType=pdf. Accessed November 7, 2014.
25. Food and Drug Administration. DepartmentofHealth and Human Services. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Available at: http://www.gpo.gov/fdsys/pkg/FR-2014-12-04/pdf/2014-28241.pdf. Accessed December 7, 2014.
26. Coscia LA, Constantinescu S, Davison J. Immunosuppressive drugs and fetal outcome. Best Pract Res Clin Obstet Gynaecol. 2014;28:1174-1187.
27. Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology. 1995;51:45-46.
28. Park-Wyllie L, Mazotta P, Pastusazak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385-392.
29. Armenti VT, Moritz MJ, Cardonick EH, et al. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs. 2002;62:2361-2375.
30. Briggs GG, Freeman RK, Yaffe SJ. Azathioprine. In: Briggs GG, Freeman RK, Yaffee SJ, eds. Drugs in Pregnancy and Lactation. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:113-116.
31. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathio-prine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol. 1985;92:233-239.
32. Danesi R, Del Tacca M. Teratogenesis and immunosuppressive treatment. Transplant Proc. 2004;36:705-707.
33. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf. 1998;19:219-232.
34. Bar Oz B, Hackman R, Einarson T, et al. Pregnancy outcomeafter cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71:1051-1055.
35. Hebral AL, Cointault O, Connan L, et al. Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen allo-immunization risk. Nephrol Dial Transplant. 2014;29:1786-1793.
36. Hebert MF, Zheng S, Hays K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation. 2013;95:908-915.
37. Kainz A, Harabacz I, Cowlrick IS, et al. Analysis of 100 pregnancy outcomesin women treated systemically with tacrolimus. Transpl Int. 2000;13:S299-S300.
38. Chu SH, Liu KL, Chiang YJ, et al. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc. 2008;40:2446-2448.
39. Jankowska I, Oldakowska-Jdynak U, Jabiry-Zieniewicz Z, et al. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant Proc. 2004; 36:3232-3233.
40. Veroux M, Corona D, Veroux P. Pregnancy under everolimus-based immunosuppression. Transpl Int. 2011;24:e115-e117.
41. Coscia LA, Constatninescu S, Moritz MJ, et al. Report from the National Transplantation Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2010:65-85.
42. Le Ray C, Coulomb A, Elefant E, et al. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol. 2004;5:1091-1094.
43. Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006; 82:1698-1702.
44. Merlob P, Stahl B, Klinger G. Tetrada of the possible myco-phenolate mofetil embryopathy: a review. Reprod Toxicol. 2009;28:105-108.
45. Constantinescu S, Pai A, Coscia L, et al. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014; 28:1163-1173.
46. Paulen ME, Folger SG, Curtis KM, et al. Contraceptive use among solid organ transplant patients: a systematic review. Contraception. 2000;82:102-112.
47. Lessan-Pezeshki M, Ghazizadeh S, Khatami MR, et al. Fertility and contraceptive issues after kidney transplantation in women. Transplant Proc. 2004;36:1405-1406.
48. Holley JL, Schmidt RJ, Bender FH, et al. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis. 1997;29:685-690.
49. Guazzelli CAF, Torloni MR, Sanches TF, et al. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation. 2008;86:669-672.
50. Szpotanska-Sikorska M, Pietrzak B, Wielgos M. Contraceptive awareness and birth control selection in female kidney and liver transplant recipients. Contraception. 2014;90:435-439.
51. French VA, Davis JS, Sayles HS, et al. Contraception and fertility awareness among women with solid organ transplants. Obstet Gynecol. 2013;122:809-814.
52. World Health Organization. Medical eligibility criteria for contraceptive use. Available at: http://www.cdc.gov/mmwr/pdf/rr/rr5904.pdf. Accessed November 12, 2014.
53. Zerner J, Doil KI, Drewry J, et al. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med. 1981;26:99.
54. Krajewski CM, Geetha D, Gomez-Lobo V. Contraceptive options for women with a history of solid-organ transplantation. Transplantation. 2013;95:1183-1186.
55. Estes CM, Westhoff C. Contraception for the transplant patient. Semin Perinatol. 2007;31:372-377.
56. Paulen ME, Folger SG, Curtis KM, et al. Contraceptive use among solid organ transplant patients: a systematic review. Contraception. 2010;82:102-112.
57. Ramhendar T, Byrne P. Use of the levonorgestrel-releasing intra-uterine system in renal transplant recipients: a retrospective case review. Contraception. 2012;86:288-289.
58. Paternoster DM, Riboni F, Bertolino M, et al. The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results. Transplant Proc. 2010;42:1162-1165.
59. Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, et al. Oral and transdermal hormonal contraception in women after kidney transplantation. Transplant Proc. 2007;39:2759-2762.
60. Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, et al. Low-dose hormonal contraception after liver transplantation. Transplant Proc. 2007;39:1530-1532.